187 related articles for article (PubMed ID: 36223199)
1. Metabolites of Cannabigerol Generated by Human Cytochrome P450s Are Bioactive.
Roy P; Dennis DG; Eschbach MD; Anand SD; Xu F; Maturano J; Hellman J; Sarlah D; Das A
Biochemistry; 2022 Nov; 61(21):2398-2408. PubMed ID: 36223199
[TBL] [Abstract][Full Text] [Related]
2. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the Mechanism of Metabolism of Cannabichromene by Human Cytochrome P450s.
Roy P; Maturano J; Hasdemir H; Lopez A; Xu F; Hellman J; Tajkhorshid E; Sarlah D; Das A
J Nat Prod; 2024 Apr; 87(4):639-651. PubMed ID: 38477310
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro metabolism of the cannabinoids.
Harvey DJ; Brown NK
Pharmacol Biochem Behav; 1991 Nov; 40(3):533-40. PubMed ID: 1806943
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
7. Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol.
Polanska HH; Petrlakova K; Papouskova B; Hendrych M; Samadian A; Storch J; Babula P; Masarik M; Vacek J
Toxicology; 2023 Apr; 488():153460. PubMed ID: 36796712
[TBL] [Abstract][Full Text] [Related]
8. The Origin and Biomedical Relevance of Cannabigerol.
Jastrząb A; Jarocka-Karpowicz I; Skrzydlewska E
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887277
[TBL] [Abstract][Full Text] [Related]
9. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives.
Calapai F; Cardia L; Esposito E; Ammendolia I; Mondello C; Lo Giudice R; Gangemi S; Calapai G; Mannucci C
Evid Based Complement Alternat Med; 2022; 2022():3336516. PubMed ID: 36397993
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.
Arnold WR; Weigle AT; Das A
J Inorg Biochem; 2018 Jul; 184():88-99. PubMed ID: 29689453
[TBL] [Abstract][Full Text] [Related]
12. Phytochemical Comparison of Medicinal Cannabis Extracts and Study of Their CYP-Mediated Interactions with Coumarinic Oral Anticoagulants.
Treyer A; Reinhardt JK; Eigenmann DE; Oufir M; Hamburger M
Med Cannabis Cannabinoids; 2023; 6(1):21-31. PubMed ID: 36814687
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
[TBL] [Abstract][Full Text] [Related]
14. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.
Lah TT; Novak M; Pena Almidon MA; Marinelli O; Žvar Baškovič B; Majc B; Mlinar M; Bošnjak R; Breznik B; Zomer R; Nabissi M
Cells; 2021 Feb; 10(2):. PubMed ID: 33562819
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
16. [Determination of 11 Cannabinoids in Cannabis sativa L. by Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-Q-TOF-MS)].
Tanaka R; Mizutani S; Kawamura M; Fuchino H; Kawahara N; Kikura-Hanajiri R
Yakugaku Zasshi; 2023; 143(4):411-418. PubMed ID: 37005243
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
[No Abstract] [Full Text] [Related]
18. CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective Na
Asano D; Hamaue S; Zahir H; Shiozawa H; Nishiya Y; Kimura T; Kazui M; Yamamura N; Ikeguchi M; Shibayama T; Inoue SI; Shinozuka T; Watanabe T; Yahara C; Watanabe N; Yoshinari K
Drug Metab Dispos; 2022 Mar; 50(3):235-242. PubMed ID: 34930785
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cannabidiol-mediated cytochrome P450 inactivation.
Bornheim LM; Everhart ET; Li J; Correia MA
Biochem Pharmacol; 1993 Mar; 45(6):1323-31. PubMed ID: 8466552
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
